DAS
TRIB

Dynamic Advisor Solutions’s Trinity Biotech TRIB Stock Holding History

Dynamic Advisor Solutions’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,000
Closed -$5.3K – 963
2023
Q4 		$5.3K Hold
2,000
– – ﹤0.01% 901
2023
Q3 		$7.35K Hold
2,000
– – ﹤0.01% 844
2023
Q2 		$9.51K Buy
+2,000
New +$9.68K ﹤0.01% 804

Other funds holding TRIB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Dynamic Advisor Solutions's TRIB Position: Q1 2024 in Review

Dynamic Advisor Solutions sold out of Trinity Biotech (TRIB) in Q1 2024, closing a stake of 2,000 shares — an estimated $5.3K sold.

Dynamic Advisor Solutions first reported a position in TRIB in Q2 2023 and held it in 3 quarters. The position peaked at $9.51K in Q2 2023. 19 funds tracked by Wall St. Rank hold TRIB as of Q1 2024.

  • Dynamic Advisor Solutions reported no remaining Trinity Biotech position as of Q1 2024 after selling out during the quarter.
  • Dynamic Advisor Solutions sold 2,000 Trinity Biotech shares in Q1 2024, an estimated $5.3K.
  • Dynamic Advisor Solutions first reported a position in Trinity Biotech in Q2 2023 and held it in 3 quarters.
  • Dynamic Advisor Solutions's Trinity Biotech position peaked at $9.51K in Q2 2023.
  • 19 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2024.

Based on Dynamic Advisor Solutions's 13F filing for Q1 2024, filed 12 Apr 2024.